We are live on ! Find out more
ETNB

89bio

Delisted

ETNB was delisted on the 29th of October, 2025.

50 hedge funds and large institutions have $226M invested in 89bio in 2021 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 13 increasing their positions, 19 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 5

4% more funds holding

Funds holding: 4850 (+2)

0.89% less ownership

Funds ownership: 86.22%85.33% (-0.89%)

32% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 19

33% less capital invested

Capital invested by funds: $339M → $226M (-$113M)

Holders
50
Holders Change
+2
Holders Change %
+4.17%
% of All Funds
0.77%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
13
Reduced
19
Closed
5
Calls
$416K
Puts
Net Calls
+$416K
Net Calls Change
+$119K
Name Holding Trade Value Shares
Change
Change in
Stake
VEA
51
Virtus ETF Advisers
New York
-$213K -10,877 Closed
SG Americas Securities
52
SG Americas Securities
New York
-$111K -5,661 Closed
Simplex Trading
53
Simplex Trading
Illinois
-$55K -3,481 Closed
Toronto Dominion Bank
54
Toronto Dominion Bank
Ontario, Canada
+$16 +1 New

ETNB Hedge Fund Activity: Q4 2021 in Review

50 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in 89bio (ETNB) for Q4 2021, worth a combined $226M — down 33% from $339M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new ETNB positions and 5 closed out — a net gain of 2 holders — while 13 added to existing stakes and 19 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $7.19M. The largest seller was Eventide Asset Management, cutting an estimated $6.65M.

  • 50 institutional investors held 89bio (ETNB) as of Q4 2021, up from 48 in Q3 2021.
  • Funds reported $226M of 89bio stock for Q4 2021, down 33% quarter-over-quarter.
  • 7 funds opened new 89bio positions in Q4 2021 and 5 closed out, a net change of +2 holders.
  • The largest 89bio buyer in Q4 2021 was Wellington Management Group, an estimated $7.19M added.
  • The largest 89bio seller in Q4 2021 was Eventide Asset Management, an estimated $6.65M sold.

Based on aggregated 13F filings for Q4 2021.